[Lyme borreliosis].
Lyme borreliosis is a multi-system infectious disease that primarily affects the skin, nervous system, heart, and joints. It is caused by the tick-borne spirochete Borrelia burgdorferi sensu lato. Diagnosis is made on the basis of clinical symptoms and supported by a positive serology. Antibiotic therapy should be started immediately after the diagnosis has been established and is administered according to stage and symptoms of the disease. Doxycycline, amoxicillin, and ceftriaxone are the antibiotics of choice. Early Lyme disease is almost always cured by one antibiotic course that also prevents subsequent disease manifestations. After antibiotic therapy of late disease manifestations, symptoms resolve only slowly and remission is usually achieved after weeks or even months. Chronic or therapy-resistant disease courses and residual symptoms after therapy are rare.
Krause
A
A
Rheumakliniken Berlin-Buch und Berlin-Wannsee, Immanuel-Krankenhaus, Königstr. 63, 14109, Berlin, Deutschland. a.krause@immanuel.de
Fingerle
V
V
D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group; D002443:Ceftriaxone / Q000627:therapeutic use; D002908:Chronic Disease; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D019353:Endemic Diseases; D005500:Follow-Up Studies; D006801:Humans; D008193:Lyme Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D020852:Lyme Neuroborreliosis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D009205:Myocarditis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology; D011379:Prognosis
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D000658:Amoxicillin; D004318:Doxycycline